Magenta Therapeutics, Inc.

NasdaqCM:MGTA Stock Report

Market Cap: US$42.2m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Magenta Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of MGTA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies12,1900.0202%
Individual Insiders5,180,7628.58%
VC/PE Firms7,130,83611.8%
Institutions8,516,82514.1%
Hedge Funds14,420,00123.9%
General Public25,121,58641.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.3%.


Top Shareholders

Top 25 shareholders own 56.4% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10%
Tang Capital Management, LLC
6,060,000US$4.2m0.17%0.69%
8.28%
Nantahala Capital Management, LLC
5,000,000US$3.5m0%0.49%
6.28%
Bruce Booth
3,791,698US$2.7m0%no data
6.28%
Atlas Venture L.P.
3,791,698US$2.7m0%0.47%
5.56%
Citadel Advisors LLC
3,360,001US$2.4m38,000%no data
5.53%
GV Management Company, LLC
3,339,138US$2.3m0%0.22%
3.26%
The Vanguard Group, Inc.
1,968,421US$1.4m0%no data
1.56%
Jason Gardner
944,954US$661.1k0%no data
0.96%
Laurion Capital Management LP
582,300US$407.4k0%0.02%
0.91%
Octagon Capital Advisors LP
550,000US$384.8k0%0.07%
0.8%
Renaissance Technologies LLC
481,700US$337.0k22.5%no data
0.76%
Acadian Asset Management LLC
457,690US$320.2k-25.5%no data
0.73%
Hellman, Jordan Management Company, Inc.
441,125US$308.6k0%0.48%
0.71%
Gilder Gagnon Howe & Co. LLC
425,858US$297.9k0%no data
0.63%
Verition Fund Management LLC
378,272US$264.6k-82.8%0.01%
0.6%
BlackRock, Inc.
364,168US$254.8k-21.9%no data
0.59%
Geode Capital Management, LLC
357,690US$250.2k0%no data
0.55%
Harvard Management Company, Inc.
332,610US$232.7k0%0.02%
0.42%
RBF Capital LLC
250,822US$175.5k0%0.01%
0.39%
Bessemer Investment Management LLC
237,292US$166.0k0%no data
0.38%
David Scadden
228,175US$159.6k0%no data
0.32%
PMG Fonds Management AG
193,500US$135.4k0%0.05%
0.29%
Two Sigma Advisers, LP
177,400US$124.1k15.2%no data
0.29%
Citadel Securities, LLC, Asset Management Arm
172,122US$120.4k0%0.36%
0.28%
Harbor Capital Advisors, Inc.
167,454US$117.1k10.1%0.03%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/09/11 07:02
End of Day Share Price 2023/09/11 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Magenta Therapeutics, Inc. is covered by 8 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kalpit PatelB. Riley Securities, Inc.
Yun ZhongBTIG
Edward WhiteH.C. Wainwright & Co.